Kronos Bio, Inc. Impairment Excluding Lessor Asset Under Operating Lease
Kronos Bio, Inc. reported Impairment Excluding Lessor Asset Under Operating Lease of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentExcludingLessorAssetUnderOperatingLease · last filed 2024-11-13
- Kronos Bio, Inc. impairment excluding lessor asset under operating lease for the quarter ending 2024-09-30 was $0.00.
- Kronos Bio, Inc. impairment excluding lessor asset under operating lease for the quarter ending 2024-06-30 was $100.00K, a 83.33% decline year-over-year.
- Kronos Bio, Inc. impairment excluding lessor asset under operating lease for the quarter ending 2024-03-31 was $1.60M.
- Kronos Bio, Inc. impairment excluding lessor asset under operating lease for the quarter ending 2023-12-31 was $0.00.
- Kronos Bio, Inc. impairment excluding lessor asset under operating lease for fiscal 2023 was $600.00K.
| Period end | Impairment Excluding Lessor Asset Under Operating Lease 3 month | Impairment Excluding Lessor Asset Under Operating Lease 6 month | Impairment Excluding Lessor Asset Under Operating Lease 9 month | Impairment Excluding Lessor Asset Under Operating Lease 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | $100.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.70M 10-Q · filed 2024-11-13 | $1.70M derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-08 | $1.70M 10-Q · filed 2024-08-08 | $1.70M derived: sum of 3 quarters · filed 2024-08-08 | $1.70M derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-03-31 | $1.60M 10-Q · filed 2024-05-09 | $1.60M derived: sum of 2 quarters · filed 2024-05-09 | $1.60M derived: sum of 3 quarters · filed 2024-11-13 | $2.20M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $600.00K derived: sum of 3 quarters · filed 2024-11-13 | $600.00K 10-K · filed 2024-03-21 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 | $600.00K derived: sum of 2 quarters · filed 2024-11-13 | $600.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $600.00K 10-Q · filed 2024-08-08 | $600.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 |